Name (Synonyms) | Correlation | |
---|---|---|
drug1317 | Study B Wiki | 1.00 |
drug1315 | Study A Wiki | 1.00 |
drug1542 | convalescent plasma Wiki | 0.50 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study is to gain critical knowledge to understand the factors influencing the outcome of a pandemic virus within the city of Basel.
Description: Identification of factors associated with (i) infection (binary, yes/no), (ii) hospitalization (binary, yes/no), (iii) requirement for ICU treatment (binary, yes/no)
Measure: Identification of factors associated with (i) infection (binary, yes/no), (ii) hospitalization (binary, yes/no), (iii) requirement for ICU treatment (binary, yes/no) Time: at baselineDescription: duration of hospitalization (in days)
Measure: duration of hospitalization (in days) Time: at baselineDescription: duration of ICU stay (in days)
Measure: duration of Intensive Care Unit (ICU) stay (in days) Time: at baselineDescription: in-hospital mortality (binary, yes/no)
Measure: in-hospital mortality (binary, yes/no) Time: at baselineDescription: Number of infected cases confirmed either by nucleic acid test (NAT) or by positive serology within the city of Basel expressed as incidence per statistical block
Measure: Number of infected cases within the city of Basel Time: at baselineDescription: Number, type, and complexity of viral genome variants and quasispecies identified by deep-sequencing during rise, peak, and contraction of the pandemic in patients and geographic areas.
Measure: whole genome sequencing to study pathogen evolution (number, type, and complexity of viral genome) Time: at baseline